U.S., April 17 -- ClinicalTrials.gov registry received information related to the study (NCT07533825) titled 'Laparoscopic Staging for Stage III Gastric Cancer' on Feb. 12.
Brief Summary: This study aims to determine, through a multicenter randomized controlled design, the impact of precision treatment guided by laparoscopic staging on overall survival (OS), surgical conversion rate, and peritoneal metastasis rate in patients with clinical stage III gastric cancer, thereby providing evidence for precision staging and treatment decision-making.
Study Start Date: Feb. 01, 2025
Study Type: INTERVENTIONAL
Condition:
Gastric Cancer (GC)
Gastric Adenocarcinoma
Intervention:
DEVICE: Laparoscopic Staging-Guided Therapy
This intervention con...